United States · Federal contract register · Supplier record

BIO-TECHNE SALES CORPORATION

Line: In vitro diagnostic substances, reagents, test kits and sets (6550)Register loaded to September 2026Compiled 17 October 2026

BIO-TECHNE SALES CORPORATION — United States · Federal contract register · Supplier record: 20 contracts, all years ($385,101 · May 2023 – Sep 2026); $249K since January 2024 (12 contracts · 3 agencies); 146th rank in the line (of 334 suppliers · 0.03%); 8 agencies never served ($12.5M on the line without BIO-TECHNE SALES CORPORATION).

Assay record ASY-US-18HHQYO0IW · Cite as: Assay Systems, “BIO-TECHNE SALES CORPORATION: 12 government contracts in the United States since 2024”, https://assay-systems.com/register/us/bio-techne-sales-corporation/

20
contracts, all years
$385,101 · May 2023 – Sep 2026
$249K
since January 2024
12 contracts · 3 agencies
146th
rank in the line
of 334 suppliers · 0.03%
8
agencies never served
$12.5M on the line without BIO-TECHNE SALES CORPORATION

Own record by year

2023 onward
$136K
$78.8K
$136K
$34.3K
2023202420252026

Who buys from BIO-TECHNE SALES CORPORATION

since January 2024
3agencies
$249Kpaid
51.3%top buyer
Department of Health and Human Services51.3%
$127,547
Department of Defense44.5%
$110,695
Department of Veterans Affairs4.2%
$10,500

Won without a rival

2024-05-06 – 2026-09-08
11uncontested awards
92%of its awards
8without a competition
3single bid

BIO-TECHNE SALES CORPORATION won 11 of its 12 public contract awards in United States without a rival from 2024-05-06 to 2026-09-08, worth $236K: 8 without a competition and 3 after a competition that drew a single bid. 4 buyers awarded it without a rival, the largest Defense Health Agency with 5.

Buyers: Defense Health Agency (5) · National Institutes of Health (4) · Centers for Disease Control and Prevention (1) · Department of Veterans Affairs (1)

Every uncontested award of BIO-TECHNE SALES CORPORATION · United States: all uncontested awards

The line

since January 2024
$534Mline value
7,757contracts
11agencies
334suppliers
61.1%held by top ten

In vitro diagnostic substances, reagents, test kits and sets (6550)

$229M
$202M
$103M
202420252026Jan–Sep
146thof 334 suppliers
$156,020BIO-TECHNE SALES CORPORATION in the line
0.03%share of the line
0.1%of $88,081,061 spent by Department of Health and Human Services
0.1%of $105,567,208 spent by Department of Defense

Agencies that buy the line and never bought from BIO-TECHNE SALES CORPORATION

8agencies
116contracts
$12,541,228since January 2024
Department of Agriculture64 contracts
$9,629,585
Department of State21 contracts
$1,650,716
Social Security Administration2 contracts
$574,150
Environmental Protection Agency5 contracts
$327,283
Department of Justice17 contracts
$204,596
Department of the Interior5 contracts
$138,850
Department of Commerce1 contract
$15,095
General Services Administration1 contract
$952

How the line is bought

by value, since 2024
41%no competition
20%one applicant
0of these to BIO-TECHNE SALES CORPORATION
Awarded directly, no competition1,326 contracts
$221,368,488 · 41.4%
Competed, several suppliers applied5,027 contracts
$208,269,874 · 39.0%
Competed, one supplier applied1,404 contracts
$104,703,431 · 19.6%

Contracts reaching their end dates

Oct 2026 – October 2027
538contracts
$121,807,157end by October 2027
102end in September 2027 · $25.8M
10in agencies never served · $1.2M
$7.9M
$3.5M
$11.2M
$9.0M
$5.4M
$10.3M
$10.8M
$11.4M
$10.2M
$4.6M
$11.8M
$25.8M
Oct 2629 contractsNov 2623 contractsDec 2653 contractsJan 2736 contractsFeb 2737 contractsMar 2758 contractsApr 2740 contractsMay 2739 contractsJun 2745 contractsJul 2722 contractsAug 2754 contractsSep 27102 contracts

Fastest-growing supplier in the line

same line
+135%growth

Supplier UEI PU6HHX2R11C7

2024 to Sep 2026
$42,184,140
2022–2023
$17,936,792

The extract

Every buying office, every contract holder, value, number and end date behind the figures above.

Request extractSee a sample extract

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.